Literature DB >> 31818187

CXCR4/TGF-β1 mediated self-differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and promoted colorectal carcinoma development.

Hao-Xiang Tan1,2, Zhi-Gang Xiao1, Tao Huang1, Zhi-Xue Fang1, Yu Liu1, Zhong-Cheng Huang1.   

Abstract

Background: Tumor microenvironment (TME) is a crucial part of tumor hallmarks. Mesenchymal stem cells (MSCs), important components of TME, are the main source of Carcinoma-associated fibroblasts (CAFs), but the mechanism of transformation regulation is still unclear. Transforming growth factor-β1 (TGF-β1), chemokine Stromal cell-derived factor-1 (SDF-1) and its endogenous receptor CXCR4 may play important roles during this process.
Methods: Co-culture technique was used to explore the effects of MSCs on the proliferation, migration and invasion of colorectal carcinoma (CRC) cells and how they induced MSCs to differentiate into CAFs. The expression of α-SMA, Vimentin, S100A4 and FAP were detected as CAFs markers. Inhibitors AMD3100 and cyclophosphamide (Cy) were pre-treated in MSCs to verify the functions of CXCR4/TGF-β1. Finally, the xenograft models in nude mice were generated to further verify this process in vivo.
Results: MSCs promoted the CRCs proliferation, invasion and migration, and induced SDF-1 expression and secretion, which dramatically up-regulated CXCR4 and TGF-β1 expression in MSCs. The levels of CAFs markers elevated in MSCs, indicating CAFs differentiation occurred in MSCs. AMD3100 and Cy treatment significantly blocked this differentiation process of MSCs by suppressing CXCR4 expression and TGF-β1 secretion. In vivo xenograft experiments also demonstrated that MSCs promoted differentiation into CAFs through CXCR4/TGF-β1 signaling in either primary tumor tissues or hepatic metastatic tissues of CRC.
Conclusion: Our studies have revealed the essential role of CXCR4/TGF-β1 axis playing in the transformation of tumor microenvironment by mediating MSCs differentiation into CAFs, promoting CRCs growth and metastasis.

Entities:  

Keywords:  CAFs; CXCR4; Carcinoma-associated fibroblasts; Colorectal carcinoma; MSCs differentiation; TGF-β1; proliferation

Mesh:

Substances:

Year:  2019        PMID: 31818187      PMCID: PMC7012141          DOI: 10.1080/15384047.2019.1685156

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  33 in total

1.  CXCR4/CXCL12 expression profile is associated with tumor microenvironment and clinical outcome of liver metastases of colorectal cancer.

Authors:  Nozomu Sakai; Hiroyuki Yoshidome; Takashi Shida; Fumio Kimura; Hiroaki Shimizu; Masayuki Ohtsuka; Dan Takeuchi; Masahiro Sakakibara; Masaru Miyazaki
Journal:  Clin Exp Metastasis       Date:  2011-11-11       Impact factor: 5.150

2.  GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.

Authors:  Yanan Peng; Zongwei Li; Zhuoyu Li
Journal:  Biochem Biophys Res Commun       Date:  2013-10-07       Impact factor: 3.575

Review 3.  Cancer invasion and the microenvironment: plasticity and reciprocity.

Authors:  Peter Friedl; Stephanie Alexander
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

4.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

5.  Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.

Authors:  Libo Zhang; Herman Yeger; Bikul Das; Meredith S Irwin; Sylvain Baruchel
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

6.  Stromal cell-derived factor-1α and transforming growth factor-β1 synergistically facilitate migration and chondrogenesis of synovium-derived stem cells through MAPK pathways.

Authors:  Yiming Wang; Jifei Chen; Wenshuai Fan; Jing Zhang; Bingxuan Hua; Bolin Sun; Liang Zhu; Xinhao Niu; Zuoqin Yan; Changan Guo
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

7.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

8.  Up-regulation of stromal cell-derived factor-1alpha and its receptor CXCR4 expression accompanied with epithelial-mesenchymal transition in human oral squamous cell carcinoma.

Authors:  Masayuki Taki; Koichiro Higashikawa; Shingo Yoneda; Shigehiro Ono; Hideo Shigeishi; Masaru Nagayama; Nobuyuki Kamata
Journal:  Oncol Rep       Date:  2008-04       Impact factor: 3.906

Review 9.  Role of transforming growth factor-beta in hematologic malignancies.

Authors:  Mei Dong; Gerard C Blobe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

10.  Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

Authors:  Pravin J Mishra; Prasun J Mishra; Rita Humeniuk; Daniel J Medina; Gabriela Alexe; Jill P Mesirov; Sridhar Ganesan; John W Glod; Debabrata Banerjee
Journal:  Cancer Res       Date:  2008-06-01       Impact factor: 12.701

View more
  10 in total

Review 1.  Tumor metastasis: Mechanistic insights and therapeutic interventions.

Authors:  Mengmeng Liu; Jing Yang; Bushu Xu; Xing Zhang
Journal:  MedComm (2020)       Date:  2021-12-02

Review 2.  The Interaction Between Long Non-Coding RNAs and Cancer-Associated Fibroblasts in Lung Cancer.

Authors:  Wenqi Ti; Jianbo Wang; Yufeng Cheng
Journal:  Front Cell Dev Biol       Date:  2022-01-11

Review 3.  The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers.

Authors:  Ze Xiang; Menglu Hua; Zhou Hao; Huang Biao; Chaojie Zhu; Guanghua Zhai; Jian Wu
Journal:  Front Immunol       Date:  2022-02-24       Impact factor: 7.561

Review 4.  Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer.

Authors:  Qian Zou; Xue Lei; Aijing Xu; Ziqi Li; Qinglian He; Xiujuan Huang; Guangxian Xu; Faqing Tian; Yuanlin Ding; Wei Zhu
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 5.  The recent advances of cancer associated fibroblasts in cancer progression and therapy.

Authors:  Chenxi Wu; Jianmei Gu; Hongbing Gu; XiaoXin Zhang; Xu Zhang; Runbi Ji
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738

Review 6.  The Role of Cancer-Associated Fibroblasts and Extracellular Vesicles in Tumorigenesis.

Authors:  Issraa Shoucair; Fernanda Weber Mello; James Jabalee; Saeideh Maleki; Cathie Garnis
Journal:  Int J Mol Sci       Date:  2020-09-17       Impact factor: 5.923

Review 7.  Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.

Authors:  Julia López de Andrés; Carmen Griñán-Lisón; Gema Jiménez; Juan Antonio Marchal
Journal:  J Hematol Oncol       Date:  2020-10-15       Impact factor: 17.388

Review 8.  The Effects of Mesenchymal Stem Cell on Colorectal Cancer.

Authors:  Jintao Yuan; Zhiping Wei; Xinwei Xu; Dickson Kofi Wiredu Ocansey; Xiu Cai; Fei Mao
Journal:  Stem Cells Int       Date:  2021-07-24       Impact factor: 5.443

9.  A Pilot Study Investigating the Expression Levels of Pluripotency-Associated Genes in Rectal Swab Samples for Colorectal Polyp and Cancer Diagnosis and Prognosis.

Authors:  Ryan Wai-Yan Sin; Dominic Chi-Chung Foo; Deepak Narayanan Iyer; May Sau-Yee Fan; Xue Li; Oswens Siu-Hung Lo; Wai-Lun Law; Lui Ng
Journal:  Stem Cells Int       Date:  2021-07-22       Impact factor: 5.443

Review 10.  The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment.

Authors:  Vladimir Mulens-Arias; José Manuel Rojas; Domingo F Barber
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.